Connect with us

Hi, what are you looking for?

Editor's Pick

In history-making visit, Harris plans to tour Minnesota abortion clinic

Vice President Harris plans to travel to Minnesota on Thursday to visit a reproductive health center that provides abortions, according to a White House official, in what is believed to be the first time an American president or vice president has toured such a facility while in office.

Her visit underscores the emphasis that Democrats are placing this election year on abortion, an issue they believe heavily plays to their advantage.

Harris, the first female vice president, has become a leading voice on reproductive rights for the Biden administration since the Supreme Court’s decision to overturn Roe v. Wade. Her visit to the Minneapolis-St. Paul area is part of a multi-state tour focused on reproductive rights.

At the facility in Minnesota, a state where there is broad access to abortion, Harris will walk through the facility and hear how the state has been impacted by other states that have enacted abortion restrictions, according to the White House official, who spoke on the condition of anonymity to preview the trip. Harris expected to be joined by Minnesota Gov. Tim Walz (D) and Rep. Betty McCollum (D-Minn.).

This post appeared first on The Washington Post

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com